RELEXXII® (Methylphenidate HCl): What Pharmacists Should Know in 2025

wholesale RELEXXII Methylphenidate HCl

As ADHD diagnoses continue to rise across all age groups, pharmacies are seeing renewed demand for effective, long-acting stimulant options. One product in growing demand is RELEXXII®, an extended-release methylphenidate hydrochloride formulation that offers reliable symptom control with once-daily dosing.

Whether you’re restocking for the back-to-school surge or simply evaluating treatment alternatives for your prescribers and patients, here’s what you should know about RELEXXII.

What Is RELEXXII®?

RELEXXII is a central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD). It contains methylphenidate HCl in an extended-release formulation, designed to last throughout the day and help reduce the need for multiple doses.

It’s a Schedule II controlled substance, so pharmacies should treat it with strict compliance handling protocols.

Why Pharmacists Are Paying Attention

  • Long-Acting Support: RELEXXII is formulated for once-daily dosing, helping patients maintain consistent symptom control during school or work hours.

  • Brand Alternative: It serves as a valuable option for prescribers looking beyond Concerta® or other branded methylphenidate ER products.

  • Growing Demand: With ADHD diagnoses trending upward in pediatric and adult populations, RELEXXII is a timely product to keep in stock.

Key Benefits for Pharmacies

Steady Patient Adherence: Extended-release means improved convenience and fewer missed doses.
Stock Optimization: Helps diversify ADHD treatment options on your shelf.
Insurance-Friendly: Often covered under a variety of commercial and Medicaid plans.
Timely Restock: Ideal for early fall when prescription volume typically spikes.

Handling and Compliance

Because RELEXXII is a Schedule II product, pharmacies must:

  • Maintain proper storage security

  • Use DEA Form 222 for ordering

  • Keep accurate, auditable dispensing records

  • Ensure staff are trained in controlled medication procedures

Wellgistics is fully licensed and DEA-compliant to handle and distribute Schedule II medications like RELEXXII. We offer fast, document-backed shipments with full transparency on chain of custody.

Ready to Stock RELEXXII?

Pharmacies looking to streamline ADHD treatment offerings should consider RELEXXII part of their late-summer inventory strategy. If you’re preparing for back-to-school demand or managing ongoing ADHD treatment volume, this is a solid item to keep available.

📦 Contact your Wellgistics rep for pricing, availability, and ordering support.

Share:

Related posts

Book your consultation!